RFPL4AL1
gene geneOn this page
Also known as RNF210B
Summary
RFPL4AL1 (ret finger protein like 4A like 1, HGNC:45147) is a protein-coding gene on chromosome 19q13.42, encoding Ret finger protein-like 4A-like protein 1 (F8VTS6).
Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Predicted to be active in cytoplasm.
Source: NCBI Gene 729974 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001277397
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:45147 |
| Approved symbol | RFPL4AL1 |
| Name | ret finger protein like 4A like 1 |
| Location | 19q13.42 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RNF210B |
| Ensembl gene | ENSG00000229292 |
| Ensembl biotype | protein_coding |
| Entrez | 729974 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000341750
RefSeq mRNA: 1 — MANE Select: NM_001277397
NM_001277397
CCDS: CCDS59425
Canonical transcript exons
ENST00000341750 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001711958 | 55769118 | 55769175 |
| ENSE00002478059 | 55772602 | 55773420 |
| ENSE00002534450 | 55771796 | 55772090 |
Expression profiles
Bgee: expression breadth broad, 32 present calls, max score 87.45.
Top tissues by expression
117 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.45 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.73 | gold quality |
| right lobe of liver | UBERON:0001114 | 56.17 | gold quality |
| granulocyte | CL:0000094 | 54.70 | gold quality |
| liver | UBERON:0002107 | 49.80 | gold quality |
| vermiform appendix | UBERON:0001154 | 44.21 | gold quality |
| colonic epithelium | UBERON:0000397 | 42.32 | gold quality |
| duodenum | UBERON:0002114 | 39.19 | gold quality |
| bone marrow cell | CL:0002092 | 38.60 | gold quality |
| leukocyte | CL:0000738 | 37.79 | gold quality |
| monocyte | CL:0000576 | 37.49 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.93 | gold quality |
| bone marrow | UBERON:0002371 | 34.22 | gold quality |
| testis | UBERON:0000473 | 33.78 | gold quality |
| lymph node | UBERON:0000029 | 33.69 | gold quality |
| blood | UBERON:0000178 | 32.99 | gold quality |
| left testis | UBERON:0004533 | 32.54 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| right testis | UBERON:0004534 | 31.77 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| islet of Langerhans | UBERON:0000006 | 30.68 | gold quality |
| urinary bladder | UBERON:0001255 | 30.36 | gold quality |
| pancreas | UBERON:0001264 | 29.90 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| gall bladder | UBERON:0002110 | 29.85 | gold quality |
| small intestine | UBERON:0002108 | 29.84 | silver quality |
| kidney | UBERON:0002113 | 29.52 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-3929 | yes | 413.02 |
| E-MTAB-6142 | no | 31.74 |
| E-ANND-3 | no | 1.30 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Rfpl4 | ENSMUSG00000035191 |
Paralogs (12): CD86 (ENSG00000114013), CD274 (ENSG00000120217), CD80 (ENSG00000121594), RFPL1 (ENSG00000128250), RFPL2 (ENSG00000128253), RFPL3 (ENSG00000128276), SPRYD4 (ENSG00000176422), RNF152 (ENSG00000176641), RNF135 (ENSG00000181481), PDCD1LG2 (ENSG00000197646), RFPL4A (ENSG00000223638), RFPL4B (ENSG00000251258)
Protein
Protein identifiers
Ret finger protein-like 4A-like protein 1 — F8VTS6 (reviewed: F8VTS6)
All UniProt accessions (1): F8VTS6
RefSeq proteins (1): NP_001264326* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001841 | Znf_RING | Domain |
| IPR001870 | B30.2/SPRY | Domain |
| IPR003877 | SPRY_dom | Domain |
| IPR003879 | Butyrophylin_SPRY | Domain |
| IPR006574 | PRY | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR013320 | ConA-like_dom_sf | Homologous_superfamily |
| IPR022723 | RDM_domain_RFPL | Domain |
| IPR037960 | SPRY/PRY_RFPL | Domain |
| IPR043136 | B30.2/SPRY_sf | Homologous_superfamily |
| IPR050143 | TRIM/RBCC | Family |
Pfam: PF00622, PF11002, PF13765, PF15227
UniProt features (5 total): sequence conflict 2, chain 1, domain 1, zinc finger region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-F8VTS6-F1 | 91.16 | 0.77 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 7 (showing top):
GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL, chr19q13
GO Biological Process (2): regulation of gene expression (GO:0010468), innate immune response (GO:0045087)
GO Molecular Function (4): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| gene expression | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| transition metal ion binding | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
158 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RFPL4AL1 | RASD1 | Q9Y272 | 186 |
| RFPL4AL1 | HOXB13 | Q92826 | 167 |
| RFPL4AL1 | RASD2 | Q96D21 | 159 |
| RFPL4AL1 | MOS | P00540 | 136 |
| RFPL4AL1 | H1-8 | Q8IZA3 | 112 |
| RFPL4AL1 | OAS3 | Q9Y6K5 | 74 |
| RFPL4AL1 | RPSA | P08865 | 72 |
| RFPL4AL1 | CXorf66 | Q5JRM2 | 72 |
| RFPL4AL1 | SMKR1 | H3BMG3 | 70 |
| RFPL4AL1 | PPP1R26 | Q5T8A7 | 70 |
| RFPL4AL1 | MRPS2 | Q9Y399 | 70 |
| RFPL4AL1 | NLRP4 | Q96MN2 | 67 |
| RFPL4AL1 | PRAMEF12 | O95522 | 53 |
| RFPL4AL1 | PRAMEF8 | Q5VWM4 | 53 |
| RFPL4AL1 | PRAMEF7 | Q5VXH5 | 53 |
IntAct
0 interactions, top by confidence:
BioGRID (8): RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS), RFPL4AL1 (Proximity Label-MS)
ESM2 similar proteins: A6NK02, A6NLU0, D4ABM4, F8VTS6, O00635, O19085, O77666, P14373, P15533, P62603, P86448, P86449, Q12899, Q2T9Z0, Q3UWZ0, Q495X7, Q58DK8, Q5BK82, Q5D7H7, Q5D7I6, Q5E9G4, Q5RBG2, Q5SZ99, Q5TM55, Q62158, Q62191, Q640S6, Q6AZZ1, Q6PGR9, Q7TPM3, Q7YR32, Q7YR33, Q7YR34, Q7YRV4, Q80X56, Q86WT6, Q8BVP1, Q8K243, Q8N7C3, Q8N9V2
Diamond homologs: A0A0E4BZH1, A0JN74, A4QPC6, A6NGJ6, A6NI03, A6NK02, A6NLU0, A7TZE6, A7TZF0, A7TZF3, A7XUX6, A7XUY5, A7XUZ6, A7XV04, A7XV07, A8MVZ5, B1H278, D4ABM4, F8S122, F8VTS6, O00478, O00481, O00635, O15553, O70355, O75677, O75678, O75679, P14373, P18892, P19474, P55803, P78410, Q02084, Q13410, Q1XHU0, Q27J48, Q2T9Z0, Q3UWZ0, Q495X7
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | RFPL4AL1 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
195 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:55771792:A:AG | acceptor_gain | 1.0000 |
| 19:55771792:ACAG:A | acceptor_loss | 1.0000 |
| 19:55771793:C:G | acceptor_gain | 1.0000 |
| 19:55771793:CAGAC:C | acceptor_loss | 1.0000 |
| 19:55771794:A:AG | acceptor_gain | 1.0000 |
| 19:55771794:AGACA:A | acceptor_loss | 1.0000 |
| 19:55771795:G:GA | acceptor_gain | 1.0000 |
| 19:55771795:GA:G | acceptor_gain | 1.0000 |
| 19:55771795:GAC:G | acceptor_gain | 1.0000 |
| 19:55771795:GACA:G | acceptor_gain | 1.0000 |
| 19:55771795:GACAT:G | acceptor_gain | 1.0000 |
| 19:55772080:G:GT | donor_gain | 1.0000 |
| 19:55772086:TCAAG:T | donor_loss | 1.0000 |
| 19:55772087:CAAGG:C | donor_loss | 1.0000 |
| 19:55772088:AAGG:A | donor_loss | 1.0000 |
| 19:55772089:AGGT:A | donor_loss | 1.0000 |
| 19:55772090:GGTAA:G | donor_loss | 1.0000 |
| 19:55772091:G:GA | donor_loss | 1.0000 |
| 19:55772091:G:GG | donor_gain | 1.0000 |
| 19:55772092:T:A | donor_loss | 1.0000 |
| 19:55772598:A:AG | acceptor_gain | 1.0000 |
| 19:55772598:ACAGT:A | acceptor_gain | 1.0000 |
| 19:55772599:C:G | acceptor_gain | 1.0000 |
| 19:55772600:A:AG | acceptor_gain | 1.0000 |
| 19:55772600:AGT:A | acceptor_gain | 1.0000 |
| 19:55772600:AGTG:A | acceptor_gain | 1.0000 |
| 19:55772601:G:GG | acceptor_gain | 1.0000 |
| 19:55772601:GT:G | acceptor_gain | 1.0000 |
| 19:55772601:GTG:G | acceptor_gain | 1.0000 |
| 19:55772601:GTGG:G | acceptor_gain | 1.0000 |
AlphaMissense
1907 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:55772715:T:C | F134L | 0.987 |
| 19:55772717:C:A | F134L | 0.987 |
| 19:55772717:C:G | F134L | 0.987 |
| 19:55772871:T:C | F186L | 0.981 |
| 19:55772873:C:A | F186L | 0.981 |
| 19:55772873:C:G | F186L | 0.981 |
| 19:55772084:T:C | F94L | 0.979 |
| 19:55772086:T:A | F94L | 0.979 |
| 19:55772086:T:G | F94L | 0.979 |
| 19:55772772:T:A | W153R | 0.979 |
| 19:55772772:T:C | W153R | 0.979 |
| 19:55772774:G:C | W153C | 0.976 |
| 19:55772774:G:T | W153C | 0.976 |
| 19:55773000:T:C | F229L | 0.976 |
| 19:55773002:T:A | F229L | 0.976 |
| 19:55773002:T:G | F229L | 0.976 |
| 19:55772802:T:A | W163R | 0.975 |
| 19:55772802:T:C | W163R | 0.975 |
| 19:55772819:C:G | C168W | 0.969 |
| 19:55772872:T:C | F186S | 0.966 |
| 19:55772818:G:A | C168Y | 0.961 |
| 19:55772734:T:A | V140D | 0.957 |
| 19:55772812:G:A | G166D | 0.956 |
| 19:55772811:G:C | G166R | 0.953 |
| 19:55772804:G:C | W163C | 0.949 |
| 19:55772804:G:T | W163C | 0.949 |
| 19:55773072:T:C | F253L | 0.949 |
| 19:55773074:T:A | F253L | 0.949 |
| 19:55773074:T:G | F253L | 0.949 |
| 19:55772817:T:C | C168R | 0.948 |
dbSNP variants (sampled 300 via entrez): RS1001568531 (19:55767281 T>C), RS1003141898 (19:55769401 A>C), RS1004909345 (19:55772674 G>A,T), RS1007697800 (19:55769317 C>G,T), RS1009410346 (19:55770559 A>G), RS1011458927 (19:55767806 G>A), RS1011824686 (19:55767436 G>A), RS1013591366 (19:55770252 A>G), RS1015934228 (19:55767967 G>A), RS1017582967 (19:55770611 G>A,T), RS1018031417 (19:55770353 A>G), RS1020048044 (19:55767843 T>C,G), RS1021718888 (19:55770259 C>A,T), RS1023476248 (19:55772939 G>A,T), RS1025895178 (19:55768709 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| zinc chromate | increases abundance, increases expression | 1 |
| gallium arsenide | increases expression | 1 |
| chromium hexavalent ion | increases abundance, increases expression | 1 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.